BERLIN--(BUSINESS WIRE)--Bayer today announced positive topline results of the Phase III study OASIS 4 investigating elinzanetant as non-hormonal treatment for moderate to severe vasomotor symptoms ...

WILMINGTON, Del.--(BUSINESS WIRE)-- Positive high-level results from the BaxHTN Phase III trial showed baxdrostat at two doses (2mg and 1mg) demonstrated a statistically significant and clinically ...

Trial achieves statistically significant primary endpoint (p=0.0006) Secondary endpoint demonstrates statistically significant overall success of Mino-Lok therapy with a greater percentage of patients ...

Achieved statistical significance on primary endpoint at week 16 for mean percent change in EASI score from baseline for all rezpegaldesleukin arms versus placebo Achieved statistical significance for ...

Genentech, a member of Roche (RHHBY), announced statistically significant and clinically meaningful results from the Phase III ALLEGORY study of Gazyva in adults with systemic lupus erythematosus on ...

Topline data from Phase 3 study in patients with Tourette syndrome shows statistical significance between ecopipam and placebo for both the primary efficacy endpoint in pediatric subjects (p = 0.0084) ...

Eli Lilly (LLY) announced topline results from the Phase 3 ATTAIN-2 trial, evaluating orforglipron, an investigational oral GLP-1 receptor agonist, in adults with obesity or overweight and type 2 ...

Viridian Therapeutics (VRDN) announced topline data from the THRIVE-2 phase 3 clinical trial of veligrotug, an intravenously delivered anti-insulin-like growth factor-1 receptor antibody, in patients ...

The phase III, double-blind LEAP2MONO study evaluated the safety and efficacy of once-daily oral venglustat versus intravenous enzyme replacement therapy (ERT), the current standard of care, given ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A second phase 3 pivotal clinical trial investigating ...

SAN FRANCISCO and SUZHOU, China, Nov. 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo WILMINGTON, Del.--(BUSINESS WIRE)-- Positive high-level results ...